Book Excerpt from The Creativity Crisis

In Chapter 1, “Yin and Yang,” author Roberta B. Ness explores the dynamic tension between innovation and risk aversion in science past and present.

Written byRoberta B. Ness
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

OXFORD UNIVERSITY PRESS, JANUARY 2015Imagine technologies so powerful they will transform society into something unimaginable. Today’s world has been spectacularly mod­ernized by products and processes that save labor, entertain, and socially connect us. We savor ever more sophisticated smartphones, pin-size sensors, GPS, and notebook computers. We appreciate vaccines that have wiped out smallpox and almost done in polio. We enjoy clean water and hygienic food. All of this—this bounty of enriched and long lives—has been bestowed on us by science and technology.

Back in 1965 Gordon Moore recognized that the number of transis­tors that can be fit into an integrated circuit was doubling about every two years. He penned Moore’s law, predicting that this rate of change would continue for at least a decade. But he was wrong: He failed to fully imagine the possibilities. The exponential explosion in electronic complexity has been unceasing ever since. Technology seems to be following a never-ending slope of advancement that is less like walking up a hill than it is like jumping straight into the sky. Our future, if Moore’s law continues to hold, will be an era of techno­logical sophistication that will continue to go beyond what our minds can now fathom. According to Ray Kurzweil, leading futurist and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies